Skip to main content
DNA Labs India

GRM7 Gene Autism Spectrum/Hyperactivity/Bipolar Disorder, GRM7 Related NGS Genetic Test

DNA Labs India | ISO 9001:2015 Certified

GRM7 Gene Autism Spectrum/Hyperactivity/Bipolar Disorder, GRM7 Related NGS Genetic Test

Short Name: GRM7 NGS Genetic Test

GRM7 Gene Autism Spectrum/Hyperactivity/Bipolar Disorder, GRM7 Related NGS Genetic Test test available at DNA Labs India for ₹20,000. Uses Next Generation Sequencing (NGS), Sanger confirmation if required on Blood or Extracted DNA or One drop Blood on FTA Card samples. Results in Results are typically available within 3 to 4 weeks from sample receipt.. Free home collection in 300+ cities across India.

NGS Genetic Test🏠 Home Collection

🩺 Medically Reviewed By

Overview

The purpose of this test is to detect sequence variants in the GRM7 gene that may contribute to autism spectrum disorder, hyperactivity, or bipolar disorder. It helps in confirming a diagnosis, guiding treatment and management decisions, and enabling genetic counselling.

Test Code
3901
ICD Code
F84.0, F90.0, F31
Price
₹20,000
Sample Type
Blood or Extracted DNA or One drop Blood on FTA Card
Result Time
Results are typically available within 3 to 4 weeks from sample receipt.
Fasting Required
No
Method
Next Generation Sequencing (NGS), Sanger confirmation if required
Step 1

Sample Collection

No special preparation is required. Fasting is not necessary. Clinical history and genetic counselling are recommended before testing.

Method: Venipuncture / FTA card blood spot

Step 2

Laboratory Analysis

A trained phlebotomist collects blood or a blood spot on the FTA card. The process is minimally invasive and takes a few minutes.

Step 3

Report Delivery

No post-collection restrictions. The sample is transported to the laboratory at ambient room temperature unless otherwise specified.

Timeline: Results are typically available within 3 to 4 weeks from sample receipt.

Patient Instructions

1
Before the Test:Pre-test genetic counselling is recommended to document family history, understand the benefits and limitations of the test, and provide informed consent.
2
During the Test:A simple blood sample or FTA card blood spot is collected. The sample is then sent to the NGS laboratory for sequencing.
3
After the Test:Patients will receive a comprehensive clinical report along with raw data files. Genetic counselling is advised to understand the implications of the result.

About This Test

Who Should Get This Test

The purpose of this test is to detect sequence variants in the GRM7 gene that may contribute to autism spectrum disorder, hyperactivity, or bipolar disorder. It helps in confirming a diagnosis, guiding treatment and management decisions, and enabling genetic counselling.

How to Prepare

  • Avoid any form of fasting before the test.
  • If on anticoagulant therapy, inform the healthcare provider prior to blood collection.
  • Ensure the FTA card is completely dried before packaging if using blood spot.
  • Label the sample correctly with name, date, and time of collection.

Doctor's Notes

Reviewed by — MBBS, MD (Medical Genetics) · Reg. No. 8532

"Genetic evaluation of GRM7 gene variants can support clinical diagnosis and management of autism spectrum disorder, hyperactivity, and bipolar disorder. Combining NGS data with careful clinical correlation is essential for accurate interpretation and counseling."

Last medically reviewed: September 7, 2026

Test Parameters & Specifications

Sample TypeBlood or Extracted DNA or One drop Blood on FTA Card
Sample Volume2 mL whole blood or 5 µg extracted DNA or 1 FTA card punch
ContainerEDTA vacutainer / DNA tube / FTA card
Collection MethodVenipuncture / FTA card blood spot

Sample Stability

Whole blood (EDTA)
Extracted DNA
FTA card
Sample Rejection Criteria:
  • Hemolysed blood sample
  • Clotted sample when blood is required
  • Improperly labelled sample
  • Frozen whole blood (unless frozen DNA is provided)

Understanding Your Results

The GRM7 gene test report should be interpreted in the context of the individual’s clinical presentation, family history, and medical evaluation. A positive result indicates the presence of a variant associated with a potential risk of the listed disorders. All results must be reviewed by a qualified clinical geneticist or specialist.
📊

Pathogenic variant detected

Indicates a strong risk for GRM7-related disorder. Clinical correlation and management planning are recommended.

📊

Likely pathogenic variant detected

Suggests a high likelihood of disease association. Additional evidence may be needed to confirm.

📊

Variant of uncertain significance (VUS)

The variant’s clinical significance is not yet clear. Family studies or further genetic testing may be needed.

📊

No pathogenic variants detected

No actionable GRM7 variants were identified. The condition might be due to other genetic or non-genetic factors.

⚠️ When to Consult a Doctor:

If the test result shows a pathogenic or likely pathogenic variant, or if you have persistent symptoms of autism, hyperactivity, or mood instability, you should consult with your referring physician or a clinical geneticist for detailed counselling and management.

Limitations

  • This test only analyses GRM7 gene variants and does not cover other genes associated with autism, hyperactivity, or bipolar disorder.
  • Regulatory regions and deep intronic mutations may not be covered.
  • Copy number variants or structural variants may not be detected by standard NGS sequencing.
  • Interpretation of variants of uncertain significance (VUS) may require further family studies.
  • A negative result does not exclude genetic or environmental causes of the condition.

Risks & Considerations

  • No significant physical risks associated with blood draw other than slight bruising or pain at the puncture site.
  • Psychological impact of potential genetic finding.
  • Possibility of genetic discrimination if result is disclosed improperly.

Interfering Factors

  • Low-quality DNA or degraded sample
  • Contamination of sample during collection
  • Presence of haematological malignancies causing clonal haematopoiesis
  • Variants in pseudogenes or homologous regions may affect detection

Compare With Similar Tests

TestGRM7 Gene Autism Spectrum/Hyperactivity/Bipolar Disorder, GRM7 Related NGS Genetic TestChromosomal Microarray (CMA)Whole Exome Sequencing (WES)Autism NGS PanelBipolar Disorder Genetic Test
ComparisonGRM7 Gene Autism Spectrum/Hyperactivity/Bipolar Disorder, GRM7 Related NGS Genetic Test

Frequently Asked Questions

What is the GRM7 gene?
The GRM7 gene encodes metabotropic glutamate receptor 7 (mGluR7) and is involved in glutamate regulation in the brain. Variations in this gene are linked to autism, hyperactivity, and bipolar disorder.
What does the GRM7 NGS genetic test include?
The test includes next-generation sequencing of the GRM7 gene, variant analysis and classification, a clinical report, and raw data files (FASTQ and VCF).
What is the cost of the GRM7 NGS genetic test?
The cost is INR 20,000 at DNA Labs India, which includes home sample collection across listed cities.
What sample types are accepted for this test?
We accept 2 mL whole blood in EDTA, 5 µg extracted DNA, or one drop of blood on an FTA card.
Is fasting required before the test?
No, fasting is not required for this test.
How long does it take to receive the results?
The turnaround time is 3 to 4 weeks from the date of sample receipt.
What is a pathogenic variant in the GRM7 gene?
A pathogenic variant is a genetic change that significantly increases an individual's risk for developing GRM7-associated conditions such as autism, hyperactivity, or bipolar disorder.
What does a negative GRM7 test result mean?
A negative result indicates that no pathogenic/likely pathogenic variants were identified in the GRM7 gene. However, this does not rule out the condition because other genes or environmental factors could contribute.
Can this test be performed on children?
Yes, the test can be performed on children with clinical indications. A genetic counselling session with the parents is strongly recommended beforehand.
Can I get the raw data files with this test?
Yes, DNA Labs India is transparent and will share raw data files (FASTQ, VCF) along with the conclusive clinical report.
Are there any risks associated with this test?
The test is safe. The only risk is minimal bruising or infection at the blood collection site. A potential psychological impact is possible when learning genetic risk information.
Is genetic counselling available?
Yes, a genetic counselling session is arranged before testing to gather family history and after testing to explain the results, risk, and implications.
Worried about the process? Our certified phlebotomists collect thousands of samples every month across India. The process takes under 5 minutes and is virtually painless. Questions? Message us on WhatsApp — we're here 7 days a week.

Related Tests

For Hospitals & Clinics

Reference Laboratory Services

We serve as a reference laboratory for hospitals and clinics across India. Send samples from your facility with same-day pickup, priority processing, and results delivered through our online portal. Competitive institutional pricing available.

LIMS Integration

Your Data Privacy

Your medical data is protected under Indian law.

Stored in India: All patient records are stored on servers located in India. No data is transferred outside the country.

DPDP Act Compliant: Under the Digital Personal Data Protection Act 2023, you can request deletion of your records at any time by contacting support.

Book Your Test

Enter your details and we'll connect you within 15 minutes.

🧬

Quick Connect

Enter your mobile number and we’ll connect you with the team.

+91

✅ Connecting you now...

🔒 Your number is used to respond to this request.